Appointment Enhances Algeta’s Commercial Capabilities and Aims to Accelerate Further Development of Alpharadin in Advanced Prostate Cancer OSLO, December 11 (HSMN NewsFeed) — Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announ…
Biopharmaceuticals, Personnel
Algeta ASA

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Algeta Appoints Andrew Kay as President and Chief Executive Officer”
Leave a Comment